ArticleJournal of the Royal Society of New Zealand2026
Genomics and Discrimination in New Zealand Health and Life Insurance.
Article in Journal of the Royal Society of New Zealand, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The role of clinical genetics in integrating cancer genetics care in Aotearoa New Zealand: improved access for improved outcomes.Journal of the Royal Society of New Zealand · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The use of genomics offers substantial benefits to society by revolutionising approaches to healthcare and personalised medicine. It enables early detection of genetic predispositions to various diseases, allowing for proactive and tailored treatment plans, access to clinical trials, and improved health outcomes. Additionally, genomic testing plays an important role in focusing research activity by advancing our understanding and knowledge of molecular contributions to diseases and driving innovation in medical science. 'Genetic testing' is sometimes used interchangeably with 'genomic testing' but they have different meanings. Genetic testing examines the functioning and composition of single genes. Genomic testing can be defined as a more complex test that analyses or provides interpretation of information about a single gene or genes, RNA, or chromosomes, with the addition of other types of molecular testing. The use of the term 'genomic testing' is future proofing our use of this type of information, as we are moving from a single gene test (genetic testing) towards more complex and nuanced methods (genomic testing).
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.